STOCK TITAN

AI / ML INNOVATIONS INC - AIMLF STOCK NEWS

Welcome to our dedicated page for AI / ML INNOVATIONS news (Ticker: AIMLF), a resource for investors and traders seeking the latest updates and insights on AI / ML INNOVATIONS stock.

AI/ML Innovations Inc. (AIMLF) is a pioneering company in the artificial intelligence (AI) and machine learning (ML) sectors, dedicated to acquiring and advancing technologies that address critical societal needs. Established to capitalize on the burgeoning fields of AI and ML, the company focuses on emerging digital health and wellbeing solutions that leverage AI, cloud computing, and digital platforms to revolutionize healthcare management.

AI/ML Innovations Inc. is committed to transforming healthcare through strategic partnerships and innovative initiatives. Its majority-owned subsidiary, Health Gauge Inc., is at the forefront of health tech innovation. Health Gauge has developed the ‘Follow Your Heart’ smartwatch, a wellness tool that uses proprietary AI PrecisionPulse Neural Network measurement technology to provide non-invasive, medical-grade accurate blood pressure readings. This product is a significant step forward in addressing the hypertension epidemic, offering users convenient and precise health monitoring.

In addition to consumer products, AI/ML Innovations Inc. supports healthcare innovators and researchers with advanced tools like The Pulse Guru, a smart sensor wearable that offers unparalleled access to raw ECG and PPG signal data. This device is instrumental for professionals needing detailed cardiovascular insights.

The company’s strategic growth also includes a recent acquisition of Naiad Labs Inc.’s product division, integrating the Long ECG Neural Net, which drastically reduces the time needed to label long ECGs, enhancing accuracy and efficiency in cardiovascular diagnostics.

AI/ML Innovations Inc. continues to expand its technological footprint with the launch of NeuralCloud Solutions Incorporated, a subsidiary focused on merging smart sensor technology with digital health. The company aims to make high-quality personal biometric data accessible to individuals globally, supported by robust AI and neural network technologies.

AI/ML Innovations Inc. trades on the Canadian Securities Exchange under the symbol AIML, the OTCQB Venture Market under AIMLF, and the Frankfurt Stock Exchange under 42FB. For more information, visit the company's website.

Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has completed a shares for debt transaction with one arm's length creditor. The company issued 302,891 shares at a deemed price of $0.08 per share to settle a debt of US$17,260 (CAD $24,231.31) for services rendered. The issued shares are subject to a four-month hold period.

Additionally, the company clarified that warrants issued in connection with a previous private placement from August 19, 2024, involving 7,845,000 units, have a three-year term instead of the initially announced two-year term. Warrant holders who received two-year warrants have been issued revised three-year replacement warrants.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.69%
Tags
AI
-
Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced a share purchase agreement to acquire Quantum Sciences , a company focused on developing digital healthcare solutions using AI, machine learning, and quantum-inspired methodologies. The acquisition is valued at $690,000, to be paid through the issuance of 10 million common shares at $0.069 per share, reflecting a 25% discount to the 20-day VWAP on the CSE.

Quantum specializes in developing products and services that enhance healthcare trajectories and workflow efficiency through meaningful patient and care provider participation. The transaction is subject to CSE approval and customary closing conditions, with no new control persons being created and no significant debt being assumed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.2%
Tags
-
Rhea-AI Summary

AI/ML Innovations Inc. (AIMLF) has announced key leadership changes and a debt settlement arrangement. The company appointed Terence Lee, a CPA with 11 years of finance experience, as Chief Financial Officer, replacing Tim Daniels who remains on the Board. Kendra Low, an experienced governance professional with over 20 years of experience, joins as Corporate Secretary.

The company granted 1,250,000 stock options to officers at an exercise price of $0.09 per share, expiring in five years. Additionally, AI/ML entered a debt settlement agreement to convert US$17,260 of debt into 302,891 shares at $0.08 per share, subject to regulatory approval.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.9%
Tags
AI
Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced the re-appointment of Follow The Money Investment Group (FTMIG) as its marketing consultant. FTMIG, based in Hampton, Ontario, will help increase company awareness through various market communications initiatives, including media distribution across multiple online channels such as their website, social media platforms, and Reddit advertisements.

The 12-month engagement began on November 25, 2024, with a fee of $32,500 plus direct expenses, to be paid from general corporate funds. FTMIG's representative Karl Boyd will lead the services from Hampton, Ontario.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.53%
Tags
AI
-
Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has completed its non-brokered private placement, raising a total of $2,872,289.94. The final tranche consisted of 24,500,615 Units at $0.065 per Unit, generating $1,592,539.98. Each Unit includes one Common Share and a two-year Warrant exercisable at $0.15 per share. The Company paid $76,032.90 in finder's fees and issued 1,169,737 broker warrants. Three insiders participated with 6,650,000 Units. The proceeds will be used for working capital requirements. Securities issued have a four-month trading restriction until March 27, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.3%
Tags
private placement AI
-
Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has completed the initial closing of its non-brokered private placement, raising $1,279,750 through the issuance of 19,688,461 Shares and Warrants. Each Unit consists of one Common Share and one Warrant, exercisable at $0.15 per share for two years. The company paid $44,070 in finder's fees and issued 504,000 broker warrants. Two company officers subscribed for 11.2% of the Units, while an insider controlling over 10% of shares subscribed for 35.5%. The proceeds will be used for working capital requirements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.52%
Tags
private placement AI
Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) announces an increase in its proposed non-brokered private placement from 20,000,000 to 40,000,000 units at $0.065 per unit, potentially raising up to $2,600,000. Each unit includes one Common Share and one Warrant exercisable at $0.15 per share within two years. The company received a 30-day extension, with closing anticipated by November 25, 2024. Proceeds will be used for general working capital. The warrant expiry can be accelerated with 30 days' notice if shares trade at $0.25 for 10 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.71%
Tags
private placement AI
-
Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced a non-brokered private placement offering of up to 20,000,000 units at $0.065 per unit, aiming to raise up to $1,300,000. Each unit consists of one common share and one warrant, exercisable at $0.15 per share for two years. The company plans to use the net proceeds for working capital requirements. The offering is subject to regulatory approvals, including from the Canadian Securities Exchange.

AI/ML Innovations focuses on artificial intelligence and machine learning in the digital health and wellbeing sector. The company has strategic partnerships with Health Gauge (70% owned), Tech2Heal (22% ownership commitment), and AI Rx Inc. (70% owned).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-48.88%
Tags
private placement AI
-
Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced an impairment loss of $1,510,668 related to its investment in minority-owned subsidiary, Tech2Heal. The impairment assessment revealed that Tech2Heal's primary asset, Alakin, is currently meeting expectations with modest sales. However, the company faces significant challenges:

1. Immediate need for substantial new capital to maintain product competitiveness.
2. Rapid advancements in artificial intelligence surpassing the company's ability to modernize its technology.
3. Difficulty in remaining competitive and attracting new customers without successful AI integration into the platform.

The company's management will provide updates on plans to develop the business as they progress.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.19%
Tags
AI
Rhea-AI Summary

AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced that the British Columbia Securities Commission (BCSC) has lifted the Management Cease Trade Order (MCTO) previously granted on August 29, 2024. This action comes after the company successfully completed all required filings for its annual and interim financial periods ending April 30, 2024, and July 31, 2024, respectively.

The MCTO was initially granted due to anticipated late filings of the company's annual audited financial statements and related documents for the financial year ended April 30, 2024. The company has now completed both the Annual Filings and the Interim Filings in accordance with Canadian securities law and regulation. With the MCTO revoked, members of management are no longer restricted from trading the company's common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11%
Tags
AI

FAQ

What is the current stock price of AI / ML INNOVATIONS (AIMLF)?

The current stock price of AI / ML INNOVATIONS (AIMLF) is $0.0588 as of December 20, 2024.

What is the market cap of AI / ML INNOVATIONS (AIMLF)?

The market cap of AI / ML INNOVATIONS (AIMLF) is approximately 8.3M.

What does AI/ML Innovations Inc. do?

AI/ML Innovations Inc. focuses on acquiring and advancing AI and ML technologies to address urgent societal needs, particularly in the digital health and wellness sectors.

What is 'Follow Your Heart'?

'Follow Your Heart' is a wellness smartwatch developed by Health Gauge Inc., a subsidiary of AI/ML Innovations Inc. It offers medical-grade accurate blood pressure measurements using AI PrecisionPulse Neural Network technology.

What are the key features of The Pulse Guru?

The Pulse Guru, developed by Health Gauge, provides continuous time-series data from ECG and PPG streams using proprietary AI PrecisionPulse Neural Network technology, offering deep cardiovascular insights for researchers and healthcare innovators.

What recent acquisitions has AI/ML Innovations Inc. made?

AI/ML Innovations Inc. recently acquired Naiad Labs Inc.'s product division, including the Long ECG Neural Net, which significantly reduces the time needed to label long ECGs.

What is NeuralCloud Solutions Incorporated?

NeuralCloud Solutions Incorporated is a wholly-owned subsidiary of AI/ML Innovations Inc., focused on advancing and monetizing the company’s smart sensor and digital health technologies through AI and neural networks.

How does AI/ML Innovations Inc. plan to expand its market presence?

The company aims to expand through strategic partnerships, innovative product launches, and the integration of advanced AI technologies in healthcare solutions, making biometric data accessible globally.

Where can I buy AI/ML Innovations Inc. products?

Products such as 'Follow Your Heart' are available through retail pharmacy channels and other outlets serving patients with hypertension.

What is the Neural Net Store?

The Neural Net Store is an online portal offering commercial access to AI/ML Innovations Inc.'s healthcare solutions as APIs or web applications, enabling easy integration into third-party applications.

How does AI/ML Innovations Inc. support the healthcare industry?

The company provides advanced AI-driven tools and solutions that offer precise health monitoring and insights, supporting healthcare professionals, researchers, and device developers in their work.

What is the significance of the Long ECG Neural Net?

The Long ECG Neural Net provides accurate and quick labeling of long ECGs, significantly reducing the time and effort required for cardiovascular diagnostics and research.

AI / ML INNOVATIONS INC

OTC:AIMLF

AIMLF Rankings

AIMLF Stock Data

8.33M
112.98M
30.49%
Health Information Services
Healthcare
Link
United States of America
Victoria